| Monica Drasheen Melvin, CNM | |
|
1300 W Terrell Ave Ste 320, Fort Worth, TX 76104-2822 | |
| (817) 250-7360 | |
| Not Available |
| Full Name | Monica Drasheen Melvin |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 1300 W Terrell Ave Ste 320, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326794157 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | (Texas) | Primary |
| Entity Name | Texas Health Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174573596 PECOS PAC ID: 4385535954 Enrollment ID: O20040323000759 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Broken bones often mean lifelong disability in the developing world, due to a lack of access to simple, inexpensive initial treatment, says the director of the University of Toronto's international surgery program.
The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Drasheen Melvin, CNM 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104-2822 Ph: (817) 250-7360 | Monica Drasheen Melvin, CNM 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104-2822 Ph: (817) 250-7360 |
News Archive
In a medical breakthrough scientists have found that gene therapy could be used to cure leukemia. Researchers at the University of Pennsylvania engineered patients' own pathogen-fighting T-cells to target a molecule found on the surface of leukemia cells. These genetically modified T-cells were grown outside of the body and infused back into patients suffering from late-stage chronic lymphocytic leukemia (CLL), which affects the blood and bone marrow and is the most common form of leukemia.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
Broken bones often mean lifelong disability in the developing world, due to a lack of access to simple, inexpensive initial treatment, says the director of the University of Toronto's international surgery program.
The University of Cambridge and Life Technologies Corporation, announced today the formation of a collaboration to advance translational research studies in key disease areas such as cancer, diabetes and neurological disorders. Through this collaboration, next generation sequencing technology will be made available to the European research and clinical communities through the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge.
› Verified 7 days ago
Crystal Rene Rose, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7016 Bryant Irvin Rd Ste 100, Fort Worth, TX 76132 Phone: 817-377-8820 Fax: 817-377-8450 | |
Candis M Hicks, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104 Phone: 817-250-7360 | |
Ashlyn E Sconyers, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 10345 Alta Vista Rd, Fort Worth, TX 76244 Phone: 817-562-2828 | |
Shannon Riley Dasilva, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 4801 Sleepy Ridge Cir, Fort Worth, TX 76133 Phone: 817-727-2066 | |
Katrina Karn, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 622 Hemphill St, Fort Worth, TX 76104 Phone: 817-878-2737 | |
Ms. Sarah Katherine Morrow, CRNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 340, Fort Worth, TX 76104 Phone: 817-702-9000 Fax: 817-882-8653 | |
Katherine Lacey Hopkins, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1300 W Terrell Ave Ste 320, Fort Worth, TX 76104 Phone: 817-250-7360 |